Health care professional communication about STI vaccines with adolescents and parents

Vaccine

Volumn 32, Issue 14, 2014, Pages 1616-1623

  Hofstetter, Annika M ^a,b   Rosenthal, Susan L ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Adolescent; Communication; Health care professional; STI; Vaccine

Indexed keywords

HEPATITIS B VACCINE; VACCINE; WART VIRUS VACCINE;

ADOLESCENT; ADOLESCENT SEXUAL BEHAVIOR; ARTICLE; AWARENESS; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COMMUNICATION SKILL; CONDYLOMA ACUMINATUM; CONVERSATION; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEPATITIS B; HIGH RISK BEHAVIOR; HUMAN; INFECTION PREVENTION; KNOWLEDGE; MIDWIFE; NURSE PRACTITIONER; PAPILLOMAVIRUS INFECTION; PARENT; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SCHOOL HEALTH NURSING; SEXUAL BEHAVIOR; SEXUAL HEALTH; SEXUAL TRANSMISSION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; VACCINATION; WART VIRUS;

ADOLESCENT; COMMUNICATION; HEALTH CARE PROFESSIONAL; STI; VACCINE;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; HEALTH COMMUNICATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; PARENTAL CONSENT; PARENTS; PATIENT EDUCATION AS TOPIC; SEXUALLY TRANSMITTED DISEASES; VACCINATION; VACCINES;

EID: 84896698346     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.035     Document Type: Article

References (107)

1. Centers for Disease Control and Prevention Ten great public health achievements-worldwide, 2001-2010. MMWR Morb Mortal Wkly Rep 2011, 60(24 (June)):814-818.
2. Low N., Broutet N., Adu-Sarkodie Y., Barton P., Hossain M., Hawkes S. Global control of sexually transmitted infections. Lancet 2006, 368(9551 (December)):2001-2016.
3. Centers for Disease Control and Prevention (CDC) Global routine vaccination coverage. MMWR Morb Mortal Wkly Rep 2011, 61(43 (November)):883-885.
4. Markowitz L.E., Tsu V., Deeks S.L., Cubie H., Wang S.A., Vicari A.S., et al. Human papillomavirus vaccine introduction-the first five years. Vaccine 2012, 30(Suppl. 5):F139-F148.
5. Hadler S.C., Dietz V.M., Okwo-Bele J.M., Cutts F.T. Immunizations in developing countries. Vaccines 2008, 1541-1572. 5th ed. S. Plotkin, W. Orenstein, P. Offit (Eds.).
6. Pitts M., Smith A., Croy S., Lyons A., Ryall R., Garland S., et al. Singaporean women's knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination. Women Health 2009, 49(4 (June)):334-351.
7. Chow S.N., Soon R., Park J.S., Pancharoen C., Qiao Y.L., Basu P., et al. Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine 2010, 28(22 (May)):3809-3817.
8. Dinh T.A., Rosenthal S.L., Doan E.D., Trang T., Pham V.H., Tran B.D., et al. Attitudes of mothers in Da Nang, Vietnam toward a human papillomavirus vaccine. J Adolesc Health 2007, 40(6 (June)):559-563.
9. Samoff E., Dunn A., VanDevanter N., Blank S., Weisfuse I.B. Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sex Transm Dis 2004, 31(7 (July)):415-420.
10. Rosenthal S.L., Kottenhahn R.K., Biro F.M., Succop P.A. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health 1995, 17(4 (October)):248-254.
11. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(5):890-895.
12. Guerry S.L., De Rosa C.J., Markowitz L.E., Walker S., Liddon N., Kerndt P.R., et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011, 29(12 (March)):2235-2241.
13. Ylitalo K.R., Lee H., Mehta N.K. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 2012, 103(1 (January)):164-169.
14. Lau M., Lin H., Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine 2012, 30(20 (April)):3112-3118.
15. Garnett G.P., Kim J.J., French K., Goldie S.J. Chapter 21: modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 2006, 24(3 (August)):178-186. S3.
16. Perkins R.B., Brogly S.B., Adams W.G., Freund K.M. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study. J Womens Health (Larchmt) 2012, 21(8 (August)):813-820.
17. Boyce T., Holmes A. Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse. PLoS ONE 2012, 7(9):e43416.
18. Seale H., Trung L., Mackie F.E., Kennedy S.E., Boros C., Marshall H., et al. A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children. Vaccine 2012, 30(49):7027-7031.
19. Carroll G., Massarelli E., Opzoomer A., Pekeles G., Pedneault M., Frappier J.Y., et al. Adolescents with chronic disease. Are they receiving comprehensive health care?. J Adolesc Health Care 1983, 4(4 (December)):261-265.
20. LaMontagne D.S., Barge S., Le N.T., Mugisha E., Penny M.E., Gandhi S., et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011, 89(11 (November)). 821-30B.
21. Binagwaho A., Wagner C.M., Gatera M., Karema C., Nutt C.T., Ngabo F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 2012, 90(8 (August)):623-628.
22. Tan J., Farrell L., Allen D.G. The attitudes of Australian gynaecologists to HPV vaccination: an ASCCP survey. Aust N Z J Obstet Gynaecol 2010, 50(5 (October)):472-477.
23. Wong L.P. Physicians' experiences with HPV vaccine delivery: evidence from developing country with multiethnic populations. Vaccine 2009, 27(10 (March)):1622-1627.
24. Kahn J.A., Cooper H.P., Vadaparampil S.T., Pence B.C., Weinberg A.D., LoCoco S.J., et al. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009, 18(8 (August)):2325-2332.
25. Conis E. Do we really need hepatitis B on the second day of life? Vaccination mandates and shifting representations of hepatitis B. J Med Humanit 2011, 32(2 (June)):155-166.
26. Leader A.E., Weiner J.L., Kelly B.J., Hornik R.C., Cappella J.N. Effects of information framing on human papillomavirus vaccination. J Womens Health (Larchmt) 2009, 18(2 (February)):225-233.
27. Juraskova I., O'Brien M., Mullan B., Bari R., Laidsaar-Powell R., McCaffery K. HPV vaccination and the effect of information framing on intentions and behaviour: an application of the theory of planned behaviour and moral norm. Int J Behav Med 2011, 19(4 (December)):518-525.
28. McRee A.L., Reiter P.L., Chantala K., Brewer N.T. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?. Cancer Epidemiol Biomarkers Prev 2010, 19(8 (August)):1937-1944.
29. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126(3 (September)):425-433.
30. Rand C.M., Schaffer S.J., Humiston S.G., Albertin C.S., Shone L.P., Heintz E.V., et al. Patient-provider communication and human papillomavirus vaccine acceptance. Clin Pediatr (Phila) 2010, 50(2 (February)):106-113.
31. Tafuri S., Martinelli D., Vece M.M., Quarto M., Germinario C., Prato R. Communication skills in HPV prevention: an audit among Italian healthcare workers. Vaccine 2010, 28(34 (August)):5609-5613.
32. Zimet G.D., Mays R.M., Sturm L.A., Ravert A.A., Perkins S.M., Juliar B.E. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 2005, 159(2 (February)):132-137.
33. Stupiansky N.W., Zimet G. STD vaccine acceptability in sexually transmitted diseases. Sexually transmitted diseases: vaccines, prevention, and control 2013, 251-272. Elsevier Inc., London. 2nd ed. L.R. Stanberry, S.L. Rosenthal (Eds.).
34. Rand C.M., Humiston S.G., Schaffer S.J., Albertin C.S., Shone L.P., Blumkin A.K., et al. Parent and adolescent perspectives about adolescent vaccine delivery: practical considerations for vaccine communication. Vaccine 2011, 29(44 (October)):7651-7658.
35. Clark S.J., Cowan A.E., Stokley S., Bilukha O., Davis M.M. Physician perspectives to inform a new recommendation for meningococcal conjugate vaccine (MCV4). J Adolesc Health 2006, 39(6 (December)):850-855.
36. Britto M.T., Artherton H.D., DeWitt T.G. Immunizing adolescents in private practice: lessons learned from hepatitis B. Prev Med Manage Care 2001, 2(3):127-134.
37. Averhoff F., Linton L., Peddecord K.M., Edwards C., Wang W., Fishbein D. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health 2004, 94(6 (June)):978-984.
38. Woodruff B.A., Stevenson J., Yusuf H., Kwong S.L., Todoroff K.P., Hadler J.L., et al. Progress toward integrating hepatitis B vaccine into routine infant immunization schedules in the United States, 1991 through 1994. Connecticut Hepatitis B Project Group. Pediatrics 1996, 97(6, Pt. 1 (June)):798-803.
39. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991, 40(RR-13):1-25.
40. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011, 60(50 (December)):1705-1708.
41. Zimet G.D., Rosenthal S.L. HPV vaccine and males: issues and challenges. Gynecol Oncol 2010, 117:S26-S31.
42. Georgousakis M., Jayasinghe S., Brotherton J., Gilroy N., Chiu C., Macartney K. Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study. Lancet Infect Dis 2012 Aug, 12(8):627-634.
43. HPV vaccine extended to boys. (2013). Available from: [cited 18.01.13]. http://www.health.gov.au/internet/ministers/publishing.nsf/Content/59C397F61CACF02FCA257A390000C65A/$File/TP059.pdf.
44. Young J.L., Bernheim R.G., Korte J.E., Stoler M.H., Guterbock T.M., Rice L.W. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol 2011, 24(6 (December)):380-385.
45. McCave E.L. Influential factors in HPV vaccination uptake among providers in four states. J Community Health 2010, 35(6 (December)):645-652.
46. Mays R.M., Zimet G.D. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sex Transm Dis 2004, 31(7 (July)):428-432.
47. Raley J.C., Followwill K.A., Zimet G.D., Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 2004, 12(3-4 (September-December)):127-133.
48. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005, 18(6 (December)):391-398.
49. Freed G.L., Bordley W.C., Clark S.J., Konrad T.R. Universal hepatitis B immunization of infants: reactions of pediatricians and family physicians over time. Pediatrics 1994, 93(5 (May)):747-751.
50. Colgrove J., Abiola S., Mello M.M. HPV vaccination mandates-lawmaking amid political and scientific controversy. N Engl J Med 2010, 363(8 (August)):785-791.
51. Onder R.F. HPV vaccine mandates: just say 'no' to the great big public health experiment. Mo Med 2008, 105(1 (January-February)):8-11.
52. Tomljenovic L., Shaw C.A. Mandatory HPV vaccination. JAMA 2012, 307(3 (January)):254. (author reply 5).
53. Haas M., Ashton T., Blum K., Christiansen T., Conis E., Crivelli L., et al. Drugs, sex, money and power: an HPV vaccine case study. Health Policy 2009, 92(2/3 (October)):288-295.
54. Gollust S.E., Dempsey A.F., Lantz P.M., Ubel P.A., Fowler E.F. Controversy undermines support for state mandates on the human papillomavirus vaccine. Health Aff (Millwood) 2010, 29(11 (November)):2041-2046.
55. Kaufmann A.M., Schneider A. New paradigm for prevention of cervical cancer. Eur J Obstet Gynecol Reprod Biol 2007, 130(1 (January)):25-29.
56. Tomljenovic L., Shaw C.A., Spinosa J.P. Human Papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?. Curr Pharm Des 2012, 19(8):1466-1487.
57. Stafford N. Germany reviews its policy on HPV vaccination for 12-17 year olds. Brit Med J 2009, 338:b1692.
58. Rondy M., van Lier A., van de Kassteele J., Rust L., de Melker H. Determinants for HPV vaccine uptake in the Netherlands: a multilevel study. Vaccine 2010, 28(9 (February)):2070-2075.
59. Slade B.A., Leidel L., Vellozzi C., Woo E.J., Hua W., Sutherland A., et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009, 302(7 (August)):750-757.
60. Vadaparampil S.T., Kahn J.A., Salmon D., Lee J.H., Quinn G.P., Roetzheim R., et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011, 29(47 (November)):8634-8641.
61. Hopkins T.G., Wood N.J., West R.M., Darling J.C. UK health professionals' attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: a West Yorkshire Study. J Paediatr Child Health 2009, 45(11 (November)):652-655.
62. Hughes C.C., Jones A.L., Feemster K.A., Fiks A.G. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr 2011, 11:74.
63. NCQA. Continuous improvement and the expansion of quality measurement. (2011). Available from: [cited 20.01.13]. http://www.ncqa.org/Portals/0/Publications/Resource%20Library/SOHC/SOHC%202011-v2-web_2.22.12.pdf.
64. Wiehe S.E., Rosenman M.B., Wang J., Katz B.P., Fortenberry J.D. Chlamydia screening among young women: individual- and provider-level differences in testing. Pediatrics 2011, 127(2 (February)):e336-e344.
65. Britto M.T., Rosenthal S.L., Taylor J., Passo M.H. Improving rheumatologists' screening for alcohol use and sexual activity. Arch Pediatr Adolesc Med 2000, 154(5 (May)):478-483.
66. Songthap A., Pitisuttithum P., Kaewkungwal J., Fungladda W., Bussaratid V., Koonsaeng S. Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers. Southeast Asian J Trop Med Public Health 2009, 40(5 (September)):1048-1056.
67. Oscarsson M.G., Dahlberg A., Tyden T. Midwives at youth clinics attitude to HPV vaccination and their role in cervical cancer prevention. Sex Reprod Health 2011, 2(4 (November)):137-142.
68. Bednarczyk R.A., Davis R., Ault K., Orenstein W., Omer S.B. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics 2012, 130(5 (November)):798-805.
69. Cummings T., Zimet G.D., Brown D., Tu W., Yang Z., Fortenberry J.D., et al. Reduction of HPV infections through vaccination among at-risk urban adolescents. Vaccine 2012, 30(37 (August)):5496-5499.
70. Forster A., Wardle J., Stephenson J., Waller J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun 2010, 15(2 (March)):205-217.
71. Mullins T.L., Zimet G.D., Rosenthal S.L., Morrow C., Ding L., Shew M., et al. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med 2012, 166(1 (January)):82-88.
72. Alderman E.M., Rieder J., Cohen M.I. The history of adolescent medicine. Pediatr Res 2003, 54(1 (July)):137-147.
73. Dinas K., Nasioutziki M., Arvanitidou O., Mavromatidis G., Loufopoulos P., Pantazis K., et al. Awareness of human papillomavirus infection, testing and vaccination in midwives and midwifery students in Greece. J Obstet Gynaecol 2009, 29(6 (August)):542-546.
74. Urasa M., Darj E. Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania. Afr Health Sci 2011, 11(1 (March)):48-57.
75. Esposito S., Bosis S., Pelucchi C., Begliatti E., Rognoni A., Bellasio M., et al. Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine 2007, 25(35 (August)):6437-6446.
76. Duval B., Gilca V., McNeil S., Dobson S., Money D., Gemmill I.M., et al. Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine 2007, 25(45 (November)):7841-7847.
77. Maheux B., Haley N., Rivard M., Gervais A. STD risk assessment and risk-reduction counseling by recently trained family physicians. Acad Med 1995, 70(8 (August)):726-728.
78. de Carvalho N.S., Teixeira L.M., Pradel E.M., Gabardo J., Joly C., Urbanetz A.A. Vaccinating against HPV: physicians' and medical students' point of view. Vaccine 2009, 27(20 (May)):2637-2640.
79. Feemster K.A., Winters S.E., Fiks A.G., Kinsman S., Kahn J.A. Pediatricians' intention to recommend human papillomavirus (HPV) vaccines to 11- to 12-year-old girls postlicensing. J Adolesc Health 2008, 43(4 (October)):408-411.
80. Kepka D., Berkowitz Z., Yabroff K.R., Roland K., Saraiya M. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?. Sex Transm Infect 2012, 88(6 (October)):433-435.
81. Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2009, 84(15 (April)):118-131.
82. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent Human Papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2 (March)):1-24.
83. Wong L.P. Young multiethnic women's attitudes toward the HPV vaccine and HPV vaccination. Int J Gynaecol Obstet 2008, 103(2 (November)):131-135.
84. Liddon N., Pulley L., Cockerham W.C., Lueschen G., Vermund S.H., Hook E.W. Parents'/guardians' willingness to vaccinate their children against genital herpes. J Adolesc Health 2005, 37(3 (September)):187-193.
85. Brewer N.T., Gottlieb S.L., Reiter P.L., McRee A.L., Liddon N., Markowitz L., et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 2010, 38(3 (March)):197-204.
86. Bair R.M., Mays R.M., Sturm L.A., Zimet G.D. Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol 2008, 21(6 (December)):329-334.
87. Wong L.P. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups. J Low Genit Tract Dis 2009, 13(2 (April)):85-93.
88. Newman P.A., Logie C. HIV vaccine acceptability: a systematic review and meta-analysis. AIDS 2010, 24(11 (July)):1749-1756.
89. Rosenthal S.L., Lewis L.M., Succop P.A., Bernstein D.I., Stanberry L.R. College students' attitudes regarding vaccination to prevent genital herpes. Sex Transm Dis 1999, 26(8 (September)):438-443.
90. Gowda C., Schaffer S.E., Dombkowski K.J., Dempsey A.F. Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents and providers. BMC Public Health 2012, 12:509.
91. Freed G.L., Clark S.J., Butchart A.T., Singer D.C., Davis M.M. Parental vaccine safety concerns in 2009. Pediatrics 2010, 125(4 (April)):654-659.
92. Darden P.M., Thompson D.M., Roberts J.R., Hale J.J., Pope C., Naifeh M., et al. Reasons for not vaccinating adolescents: national immunization survey of teens, 2008-2010. Pediatrics 2013, 131(4 (April)):645-651.
93. Smith P.J., Kennedy A.M., Wooten K., Gust D.A., Pickering L.K. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 2006, 118(5 (November)). e1287-e1292.
94. Szilagyi P.G., Rand C.M., McLaurin J., Tan L., Britto M., Francis A., et al. Delivering adolescent vaccinations in the medical home: a new era?. Pediatrics 2008, 121(Suppl. 1 (January)):S15-S24.
95. Sara Test F., Caskey R., Rankin K.M. The relationship between receiving care within a medical home and HPV Vaccine receipt for adolescent girls: results of the 2007 national survey of children's health. Matern Child Health J 2012, 17(2):274-281.
96. Bennett D.L., Tonkin R.S. International developments in adolescent health care: a story of advocacy and achievement. J Adolesc Health 2003, 33(4 (October)):240-251.
97. Broughton D.E., Beigi R.H., Switzer G.E., Raker C.A., Anderson B.L. Obstetric health care workers' attitudes and beliefs regarding influenza vaccination in pregnancy. Obstet Gynecol 2009, 114(5 (November)):981-987.
98. Javanbakht M., Stahlman S., Walker S., Gottlieb S., Markowitz L., Liddon N., et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine 2012, 30(30 (June)):4511-4516.
99. World Health Organization. Vaccine introduction guidelines: adding a vaccine to a national immunization programme: decision and implementation. 2005. Available from: [cited 14.01.13]. http://apps.who.int/iris/bitstream/10665/69179/1/WHO_IVB_05.18.pdf.
100. World Health Organization. Adolescent job aid: a handy desk reference tool for primary level health workers. (2010). Available from: [cited 19.01.13]. http://www.who.int/maternal_child_adolescent/documents/9789241599962/en/index.html.
101. World Health Organization. Making health services adolescent friendly: developing national quality standards for adolescent-friendly health services. (2012). Available from: [cited 19.01.13]. http://www.who.int/maternal_child_adolescent/documents/adolescent_friendly_services/en/index.html.
102. Wong L.P. HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine 2009, 27(9 (February)):1410-1415.
103. Sheinfeld Gorin S.N., Glenn B.A., Perkins R.B. The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps. Adv Ther 2011, 28(8 (August)):615-639.
104. Pfeffer B., Bakeera-Kitaka S., LaRussa P., Rosenthal S.L. Collaboration with in-country colleagues: using workshops to enhance adolescent health care delivery. SAHM Matters 2012, 24:2.
105. Szilagyi P.G., Bordley C., Vann J.C., Chelminski A., Kraus R.M., Margolis P.A., et al. Effect of patient reminder/recall interventions on immunization rates: A review. JAMA 2000, 284(14 (October)):1820-1827.
106. Fiks A.G., Hunter K.F., Localio A.R., Grundmeier R.W., Bryant-Stephens T., Luberti A.A., et al. Impact of electronic health record-based alerts on influenza vaccination for children with asthma. Pediatrics 2009, 124(1 (July)):159-169.
107. Mayne S., Karavite D., Grundmeier R.W., Localio R., Feemster K., Debartolo E., et al. The implementation and acceptability of an HPV vaccination decision support system directed at both clinicians and families. AMIA Annu Symp Proc 2012, 2012:616-624.